Ariane Steindl, PhD, Medical University of Vienna, Vienna, Austria, discusses recent advances in the systemic treatment of brain metastases, including trastuzumab deruxtecan which demonstrates activity within the brain, as well as the importance of gaining real-world data of patients treated with systemic agents. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.